Neurona Therapeutics logo

Neurona Therapeutics, Inc.

Biotechnology

Neurona Therapeutics Stock

Neurona Therapeutics is a clinical-stage biotherapeutics company focused on developing regenerative neural cell therapies for chronic neurological disorders. It creates specific neuronal, glial, and gene-edited cell therapy candidates aimed at repairing dysregulated neural circuits and providing curative treatments.

For more Neurona Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Management Team

Cory Nicholas Ph.D. Co-Founder & Chief Executive Officer
James Stutz Chief Financial Officer & Chief Business Officer
Gautam Banik Ph.D. Chief Technology Officer
Catherine Priest Ph.D. Chief Development Officer
Arturo Álvarez-Buylla Ph.D. Co-Founder & Scientific Advisor
John Rubenstein Ph.D. Co-Founder & Scientific Advisor
Arnold Kriegstein Ph.D. Co-Founder & Scientific Advisor
Manher Joshi MD Chief Medical Officer

Funding Information